Stocks · Health care · Medicinal Chemicals & Botanical Products

Trulieve Cannabis Corp.

TRLV Clue Score48
United States Fiscal year ends December CIK 0001754195
$10.67 +2.89% Close, 9 Oct 2026

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close
10.67 on 9 Oct 2026
13 10 8 Jun 2026 Aug 2026 Oct 2026 10 Jun 2026 $11.50 11 Jun 2026 $11.55 12 Jun 2026 $10.35 15 Jun 2026 $9.86 16 Jun 2026 $9.40 17 Jun 2026 $9.45 18 Jun 2026 $10.10 22 Jun 2026 $9.12 23 Jun 2026 $8.53 24 Jun 2026 $8.50 25 Jun 2026 $8.52 26 Jun 2026 $8.99 29 Jun 2026 $9.24 30 Jun 2026 $9.83 1 Jul 2026 $9.54 2 Jul 2026 $9.78 6 Jul 2026 $8.82 7 Jul 2026 $8.93 8 Jul 2026 $8.89 9 Jul 2026 $8.84 10 Jul 2026 $8.62 13 Jul 2026 $9.04 14 Jul 2026 $9.06 15 Jul 2026 $8.63 16 Jul 2026 $8.41 17 Jul 2026 $8.79 20 Jul 2026 $8.76 21 Jul 2026 $8.96 22 Jul 2026 $8.67 23 Jul 2026 $8.55 24 Jul 2026 $8.36 27 Jul 2026 $8.33 28 Jul 2026 $8.33 29 Jul 2026 $8.06 30 Jul 2026 $8.57 31 Jul 2026 $8.65 3 Aug 2026 $8.60 4 Aug 2026 $8.89 5 Aug 2026 $8.44 6 Aug 2026 $9.00 7 Aug 2026 $8.75 10 Aug 2026 $9.08 11 Aug 2026 $9.30 12 Aug 2026 $9.11 13 Aug 2026 $9.60 14 Aug 2026 $9.65 17 Aug 2026 $9.47 18 Aug 2026 $9.69 19 Aug 2026 $10.09 20 Aug 2026 $10.25 21 Aug 2026 $11.10 24 Aug 2026 $11.14 25 Aug 2026 $11.32 26 Aug 2026 $11.43 27 Aug 2026 $11.03 28 Aug 2026 $11.82 31 Aug 2026 $11.51 1 Sep 2026 $11.74 2 Sep 2026 $11.69 3 Sep 2026 $11.99 4 Sep 2026 $12.11 8 Sep 2026 $12.43 9 Sep 2026 $11.77 10 Sep 2026 $11.32 11 Sep 2026 $11.31 14 Sep 2026 $11.62 15 Sep 2026 $11.60 16 Sep 2026 $11.55 17 Sep 2026 $11.65 18 Sep 2026 $11.07 21 Sep 2026 $11.50 22 Sep 2026 $12.47 23 Sep 2026 $12.54 24 Sep 2026 $12.27 25 Sep 2026 $12.21 28 Sep 2026 $12.34 29 Sep 2026 $12.41 30 Sep 2026 $10.90 1 Oct 2026 $10.87 2 Oct 2026 $10.72 5 Oct 2026 $10.65 6 Oct 2026 $10.65 7 Oct 2026 $10.78 8 Oct 2026 $10.37 9 Oct 2026 $10.67 Rivers Kim A. Chairman and CEO Sold on a plan $1.29M 17 Jun 2026 · at $9.36 · 4.3% of stake Rivers Kim A. Chairman and CEO Sold on a plan $1.32M 18 Jun 2026 · at $9.46 · 4.6% of stake Rivers Kim A. Chairman and CEO Sold on a plan $1.92M 22 Jun 2026 · at $9.35 · 7.1% of stake Rivers Kim A. Chairman and CEO Sold on a plan $3.22M 23 Jun 2026 · at $8.47 · 14.1% of stake Rivers Kim A. Chairman and CEO Sold on a plan $3.27M 24 Jun 2026 · at $8.17 · 17.3% of stake Rivers Kim A. Chairman and CEO Sold on a plan $2.45M 25 Jun 2026 · at $8.17 · 15.7% of stake Rivers Kim A. Chairman and CEO Sold on a plan $1.20M 26 Jun 2026 · at $8.76 · 8.5% of stake
0 buys0 sales at will7 planned sales

Key numbers

Fiscal year 2025, ended 31 Dec 2025, as filed
Revenue
$1.18B
Net income
$116.38M
Free cash flow
$228.63M
Gross margin
60.2%
Operating margin
12.2%
Net margin
-9.9%
Return on equity
-10.2%
Return on capital
4.5%
Debt to equity
0.12
Revenue growth, 1 yr
-0.5%
Revenue growth, 5 yr
17.8% a year

Revenue and profit

Fiscal years, as filed with the SEC · point at a year for the detail
Full statements →
522M 63M FY20 Fiscal year 2020 Revenue $521.53M Net income $63.00M Margin 12.1% 932M 17M FY21 Fiscal year 2021 Revenue $931.93M Net income $17.45M Margin 1.9% · growth +78.7% 1.2B -253M FY22 Fiscal year 2022 Revenue $1.22B Net income $252.73M Margin -20.7% · growth +30.7% 1.1B 0K FY23 Fiscal year 2023 Revenue $1.13B Net income $0.00 Margin 0.0% · growth -7.3% 1.2B 0K FY24 Fiscal year 2024 Revenue $1.19B Net income $0.00 Margin 0.0% · growth +5.1% 1.2B 0K FY25 Fiscal year 2025 Revenue $1.18B Net income $0.00 Margin 0.0% · growth -0.4%
RevenueNet incomeLoss

Latest insider transactions

From Form 4, most recent first
All of them →
DateInsiderTypeValueOf own stake
26 Jun 2026 Rivers Kim A.
Chairman and CEO
Sold on a plan $1.20M 8.5%
25 Jun 2026 Rivers Kim A.
Chairman and CEO
Sold on a plan $2.45M 15.7%
24 Jun 2026 Rivers Kim A.
Chairman and CEO
Sold on a plan $3.27M 17.3%
23 Jun 2026 Rivers Kim A.
Chairman and CEO
Sold on a plan $3.22M 14.1%
22 Jun 2026 Rivers Kim A.
Chairman and CEO
Sold on a plan $1.92M 7.1%
18 Jun 2026 Rivers Kim A.
Chairman and CEO
Sold on a plan $1.32M 4.6%